PABLO
MARTÍNEZ-LAGE ÁLVAREZ
Vrije Universiteit Brussel
Bruselas, BélgicaPublicaciones en colaboración con investigadores/as de Vrije Universiteit Brussel (10)
2024
-
Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
Fluids and Barriers of the CNS, Vol. 21, Núm. 1
2022
-
Predicting AT(N) pathologies in Alzheimer’s disease from blood-based proteomic data using neural networks
Frontiers in Aging Neuroscience, Vol. 14
-
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
JAMA Neurology, Vol. 79, Núm. 3, pp. 228-243
2021
-
Sex-specific metabolic pathways were associated with alzheimer’s disease (Ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery cohort
Biomedicines, Vol. 9, Núm. 11
-
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Alzheimer's and Dementia, Vol. 17, Núm. 10, pp. 1628-1640
2020
-
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology
Journal of Alzheimer's Disease, Vol. 77, Núm. 3, pp. 1353-1368
-
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
Translational Psychiatry, Vol. 10, Núm. 1
-
Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
Journal of Alzheimer's Disease, Vol. 74, Núm. 1, pp. 213-225
2019
-
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 5, pp. 933-938
-
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Alzheimer's and Dementia, Vol. 15, Núm. 11, pp. 1478-1488